Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...
Fortress and its majority-owned subsidiary, Cyprium Therapeutics, said the FDA has accepted an NDA resubmission for CUTX-101, or copper histidinate, a treatment for children who suffer from Menkes ...
Scotland's MiAlgae is building a commercial-scale facility to upcycle whisky waste into fish-free omega-3, with a £3M ...
This company has lodged a key submission which will pave the way for sales of its heart failure software in the large US ...
Stockhead on MSN
Health Kick podcast: Health Food Symmetry’s sugarcane solution
Tim Boreham chats with Health Food Symmetry's Gordon Edwards to go into the company's unique whole-plant prebiotics. ... Read ...
Scientists in China used CRISPR to engineer a fungus that churns out protein more efficiently and with a lighter ...
New Team Members Bring Experience and Strategic VisionMINNEAPOLIS, Dec.15, 2025 /PRNewswire/ -- Pivot Bio, one of the world's leading innovative agtech ...
Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
Cell therapy company Link Cell Therapies is launching with $60 million and a mission to develop potent CAR-T therapies that ...
Ringside’s phase 3 findings reveal the potential varegacestat has to deliver “best-in-class results in a convenient, ...
For $950 million upfront, Sobi will gain ownership to pozdeutinurad, an oral URAT1 inhibitor that performed well in Phase II ...
Dr Rahul Banerjee discusses ASH 2025 and bispecific antibodies in myeloma, including data from MajesTEC-3, IFM2021-01, and IMMUNOPLANT.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback